Louvres, France

Fabrice Viviani

This inventor holds 22 USPTO granted patents and 1 published patent application and 8 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Aventis Pharma S.a., Sanofi, Novexel. Active years: 2002-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fabrice Viviani. Retrieved from https://idiyas.com/inventor/fabrice-viviani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 22 

% Patents Active = 22.7

 

Average Co-Inventor Count = 7.9

ph-index = 7

Forward Citations = 156(Granted Patents)


Location History:

  • Louvre, FR (2007)
  • Louvres, FR (2002 - 2011)
  • Avenheim, FR (2011)
  • Paris, FR (2014 - 2015)

Company Filing History:


Years Active: 2002-2015

Loading Chart...
Loading Chart...
Areas of Expertise:
mTOR-Inhibitors
Quinazolinedione Derivatives
Piperidine Derivatives
Tetrahydropyrimidine
Indazoles
Pyrazolopyridines
Pyrrolopyridines
Aza-Indazoles
Pharmaceutical Compositions
Cardiovascular Applications
Heterocycles
Compositions
22 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Fabrice Viviani

Introduction

Fabrice Viviani, an esteemed inventor based in Louvres, France, has made significant contributions to the field of pharmaceuticals with an impressive portfolio of 22 patents. His inventive work primarily focuses on the development of innovative therapeutic compounds aimed at addressing critical health issues.

Latest Patents

Among his latest patents, Fabrice has developed pyrimidooxazocine derivatives recognized as mTOR-inhibitors. This invention pertains to bicyclic heterocyclic derivatives outlined in general formula (I), which are pivotal for creating new therapeutic strategies. Additionally, he holds a patent for the therapeutic applications of quinazolinedione derivatives, focusing on their use as medicaments for treating and preventing cardiovascular diseases.

Career Highlights

Fabrice Viviani's career is marked by his tenure at prominent pharmaceutical companies such as Aventis Pharma and Sanofi, where he has employed his expertise to drive forward innovative healthcare solutions. His contributions in these significant institutions have reinforced their commitment to advancing medical treatments.

Collaborations

Throughout his career, Fabrice has collaborated with distinguished professionals including Michel Tabart and Baptiste Ronan. These collaborative efforts have facilitated the development of groundbreaking inventions, enhancing both research outcomes and therapeutic applications.

Conclusion

Fabrice Viviani's work exemplifies a profound dedication to innovation in pharmaceuticals. His patents not only highlight his creativity and scientific acumen but also illustrate his commitment to improving health outcomes through new therapeutic compounds. With a robust foundation and continued collaboration, he remains a key figure in the advancement of medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…